Latest News

  • ‘Better Stethoscope’ Could be First Step in Diagnosing Heart Valve Disease

    Diagnostics World | The stethoscope, despite being more than 200 years old, is not an easily retired diagnostic device. It remains symbolic of the medical profession, even if many physicians no longer wear them and those that do are not particularly good at using them.

    May 8, 2025
  • Saliva Test Could Help Oncologists Know When to Avoid Common Cancer Drug

    Diagnostics World | Cleveland Diagnostics announced the results of a new independent study published in Urology; Illumina and Tempus AI collaborate to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation; LinusBio announced a new partnership with the BRAIN Foundation to support advancing autism biomarker research and facilitating early identification and intervention of autism spectrum disorder; and more.

    May 6, 2025
  • By Focusing on Nearer-Term Incremental Change, We Can Pave the Way to Multi-Cancer Early Detection Tests

    Diagnostics World | One of the most important tools we have to reduce mortality from cancer is early detection. Mammograms have had a significant impact in improving outcomes for patients with breast cancer, and colonoscopies have done the same for patients with colorectal cancer. But despite broad recognition of the importance of early cancer detection, our ability to screen for a wide range of cancers is quite limited. In fact, there are only five cancers for which Medicare is directed to pay for screening: breast, cervical, colon, lung, and prostate.

    May 2, 2025
  • Cleveland Diagnostics’ New Study, Illumina, Tempus AI Collaborate, LinusBio, BRAIN Foundation Partnership, More

    Diagnostics World | Cleveland Diagnostics announced the results of a new independent study published in Urology; Illumina and Tempus AI collaborate to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation; LinusBio announced a new partnership with the BRAIN Foundation to support advancing autism biomarker research and facilitating early identification and intervention of autism spectrum disorder; and more.

    Apr 30, 2025
  • Follow the Money: Degenerative Eye Disease Treatments, Antibodies for Multiple Diseases, More

    Diagnostics World | Atsena will advance their lead program, ATSN-201, for the treatment of a genetic condition that is typically diagnosed in childhood and leads to blindness later in life; Merida Biosciences plan to develop antibody-like therapeutics to help treat multiple diseases; and more.

    Apr 29, 2025
  • Researchers Identify Better Biomarker for Stroke and Dementia Risk

    Diagnostics World | Over the past few years, a multidisciplinary team of experts has been spreading the news that an abnormality of the heart’s left atrium (LA), known as LA myopathy, can be a marker of elevated risk of stroke and dementia—even in the absence of atrial fibrillation (AFib). The current “gap in the field” is that there is no established way to characterize the condition.

    Apr 24, 2025
  • ‘Lab-in-a-Box’ Diagnostics in the Post-Theranos Era

    Diagnostics World | The clinical relevance and limitations of so-called “lab-in-a-box” (LIAB) diagnostics, which surged in popularity during the COVID pandemic, have since that time been under considerable scrutiny, most notably among investors still spooked by the notorious Theranos scandal. One of the more enduring problems among LIAB developers is that they tend to get “blinded by the beauty” of their technology.

    Apr 22, 2025
  • Immunosensor Could Improve Blood-Based Testing for Colorectal Cancer

    Diagnostics World | Researchers at The University of Texas at El Paso (UTEP) are developing a point-of-care device for diagnosing colorectal cancer which, like blood glucose devices, uses electrochemical sensors. The microchip electrode features an immunosensor that detects disease biomarkers in a drop of blood, opening the possibility of an accessible, inexpensive test for the nation’s second leading cause of cancer-related deaths.

    Apr 17, 2025
  • ‘Funky Shape’ Gets Magnetic Robots Rolling in the Colon in Search of Cancer

    Diagnostics World | Magnetic flexible endoscopes (MFEs) have up to now had a few disadvantages limiting their use inside the human body for performing virtual biopsies, notably navigation-related difficulties related to their traditional cylindrical shape. These robot-assisted devices use magnetic forces to propel and maneuver through lumens like the colon, but rotation happens in only two directions that limits the scope's ability to effectively perform procedures.

    Apr 16, 2025
  • Latest Biological Clock Ties ‘Bioenergetic Capacity’ to Alzheimer’s Risk

    Diagnostics World | The “bioenergetic capacity” of individuals, as marked by the level of certain cognition-associated molecules in the blood, could potentially be predictive of the risk of developing Alzheimer’s and other age-related diseases. A simulated clinical trial suggests that turning back the wheels on that biological clock could be just as effective at slowing cognitive decline as the latest drug to be approved for that purpose by the U.S. Food and Drug Administration.

    Apr 15, 2025
  • Diagnostic Imaging Developments: Researchers Pursue New Tools, Technologies, and Techniques to Read X-Rays, Enhance Image Quality, and Improve Visualization

    Diagnostics World | Researchers worldwide are looking to revamp traditional approaches to medical imaging and develop alternative solutions that could improve visualization, speed, and accuracy in diagnostic settings. At the University of Arkansas, for example, one group is developing an AI tool designed to help radiologists and doctors analyze chest X-rays and computed tomography (CT) scans, with an emphasis on understanding how the AI assistant arrives at its conclusions.

    Apr 10, 2025
  • Throat Swabs May Hold Clues to General Health of Older Individuals

    Diagnostics World | The impact of the throat microbiome on the health of older individuals has gone unappreciated, especially among individuals being cared for in long-term care facilities. One big reason is that they are largely isolated and often forgotten by the public, even as these facilities have become home to a greater proportion of the overall population.

    Apr 8, 2025
  • Danger Ahead: How AI-Enabled Remote Cardiac Monitoring Technology Can Mitigate the Growing AFib Crisis

    Diagnostics World | Atrial Fibrillation (AFib) is a fast-growing public health crisis—three times more common than once thought. Today, at least 10.55 million US adults have AFib, far exceeding the 3.3 million cases researchers predicted for the year 2020 in 1996. And this crisis is only growing.

    Apr 4, 2025
  • Babson Diagnostics’ BetterWay Blood Test Available at National Retailer

    Diagnostics World | Last week, Babson Diagnostics entered an agreement with Sam’s Club to offer BetterWay blood testing. BetterWay is currently available in seven Sam’s Club pharmacies in the greater Austin area. The agreement with Sam’s Club marks a significant milestone for accessible blood testing for patients.

    Apr 3, 2025
  • Texas District Court Vacates FDA LDT Rule

    Diagnostics World | The U.S. District Court for the Eastern District of Texas granted a motion for summary judgment yesterday, vacating the FDA rule that would have regulated LDTs as medical devices under the Federal Food, Drug and Cosmetic Act.

    Apr 1, 2025
  • PathAI’s Pathology Assessment Tool, Mayo Clinic Collaboration, More

    Diagnostics World | PathAI received full qualification for AIM-MASH AI Assist1; Mayo Clinic Laboratories and Amprion announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the United States; and more.

    Mar 27, 2025
  • Follow the Money: Shingles Vaccine, Blood Stem Cell Therapies, More

    Diagnostics World | Curevo will advance development of amezosvatein, the company’s vaccine for shingles; Garuda aims to address the growing need for off-the-shelf and cost-effective solution to stem cell transplants; and more.

    Mar 26, 2025
  • GE HealthCare, NVIDIA Pursue Autonomous X-Ray, Ultrasound

    Diagnostics World | GE HealthCare announced a collaboration this week with NVIDIA, expanding the existing 16-year relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound.

    Mar 20, 2025
  • Device Predicts Metastatic Risk by Measuring Stickiness of Cancer Cells

    Diagnostics World | Based on the discovery that the adhesion strength of cancer cells scales inversely proportional to the invasiveness of a tumor, researchers at University of California, San Diego have built a microfluidic device with the hope that it can be used in the future to diagnose the metastatic potential of ductal carcinoma in situ (DCIS) breast cancer tumors.

    Mar 19, 2025
  • Early Bladder Cancer Detection Just the Beginning for This At-Home Urine Test

    Diagnostics World | The incidence of bladder cancer is rising significantly due to population aging and, while survival rates are relatively high, when diagnosed late patients may need to undergo bladder removal regardless of survival. Early detection and treatment of bladder cancer are therefore crucial to preserving the organ and maintaining the patient’s quality of life.

    Mar 18, 2025